FDA links once-promising pain drugs to bone decay

March 8, 2012 8:08:41 AM PST
Some of the world's largest drugmakers face an uphill battle next week in their bid to revive a class of experimental arthritis drugs sidelined by safety concerns for nearly two years.

Load Comments